Alector, Inc. (ALEC) stock

ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3069% below fair value

$2.54+0.09 (+3.67%)

Close on Nov 13, 2026Market cap $283.61MP/E 7.3Yield –

Alector gross margin

Gross margin is gross profit as a percentage of revenue.

Alector has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ALEC.

Revenue growth151.2% · median 18.7%

Operating margin20.2% · median -160.1%

Net margin23.9% · median -208.6%

Advertisement
300 × 250

See a number that looks wrong?